PerkinElmer, Inc.

622 articles with PerkinElmer, Inc.

• PerkinElmer Launches EUROIMMUN ELISA for Detection of Aspergillus Infections

  8/5/2019

  PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the launch of the new EUROIMMUN Aspergillus Antigen ELISA.

• PerkinElmer Announces Financial Results for the Second Quarter of 2019

  7/29/2019

  PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial results for the second quarter ended June 30, 2019.

• PerkinElmer Board Declares Quarterly Dividend payable on November 8, 2019

  7/25/2019

  The Board of Directors of PerkinElmer, Inc., declared a regular quarterly dividend of $0.07 per share of common stock on July 25, 2019.

• PerkinElmer and EverlyWell Announce Collaboration to Expand U.S. At-Home Health Test Market

  7/24/2019

  Combines PerkinElmer’s expertise in immunodiagnostic testing and state-of-the-art genomics program with EverlyWell’s consumer health offerings

• PerkinElmer to Hold Earnings Call on Monday, July 29, 2019

  7/8/2019

  PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that on Monday, July 29, 2019, after market close, the Company will release second quarter 2019 results.

• FDNA and PerkinElmer Announce Collaboration to Offer Enhanced Genetic Testing Augmented by AI and Facial Analysis

  6/25/2019

  Together, they will offer genomic services paired with next-generation phenotyping technologies for more efficient and accurate diagnoses.

• PerkinElmer to Present at Goldman Sachs Global Healthcare Conference - May 29, 2019

  5/29/2019

  PerkinElmer, Inc. announced that the Company will present at the Goldman Sachs 40th Annual Global Healthcare Conference on Wednesday, June 12, 2019, at 2:40 p.m. PT in Rancho Palos Verdes, California.

• PerkinElmer Board Declares Quarterly Dividend - April 25, 2019

  4/25/2019

  The Board of Directors of PerkinElmer, Inc., declared a regular quarterly dividend of $0.07 per share of common stock on April 25, 2019.

• PerkinElmer Announces Financial Results for the First Quarter of 2019

  4/25/2019

  PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial results for the first quarter ended March 31, 2019.

• PerkinElmer Joins Accenture’s Life Sciences Ecosystem to Help Drive Innovation in Drug Discovery and Scientific Research

  4/16/2019

  Announcement at 2019 Bio-IT World Conference & Expo syncs with PerkinElmer’s strategy to get labs from big data overload to research insights faster and easier

• PerkinElmer to Hold Earnings Call on Thursday, April 25, 2019

  4/11/2019

  PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that on Thursday, April 25, 2019, after market close, the Company will release first quarter 2019 results.

• PerkinElmer Genomics Introduces Physician-Ordered Genetic Screening Test for Proactive Health Management

  4/2/2019

  Available in Helix’s DNA marketplace, GenePrism: Actionable Insights is the first clinical-grade DNA test available to health individuals that analyzes all 59 medically actionable genes identified by the American College of Medical Genetics and Genomics

• PerkinElmer to Present at Cowen and Company 39th Annual Health Care Conference

  2/22/2019

  PerkinElmer, Inc., a global leader committed to innovating for a healthier world, announced that the Company will present at the Cowen and Company 39th Annual Health Care Conference on Monday, March 11, 2019, at 1:30 p.m. ET at the Marriott Copley Place in Boston.

• PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year 2018

  1/31/2019

  PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial results for the fourth quarter and full year ended December 30, 2018.

• PerkinElmer Board Declares Quarterly Dividend on January 24, 2019

  1/24/2019

  The Board of Directors of PerkinElmer, Inc. (NYSE: PKI), declared a regular quarterly dividend of $0.07 per share of common stock on January 24, 2019.

• PerkinElmer to Hold Earnings Call on Thursday, January 31, 2019

  1/4/2019

  PerkinElmer, Inc. announced that on Thursday, January 31, 2019, after market close, the Company will release fourth quarter 2018 results

• PerkinElmer to Present at J.P. Morgan 37th Annual Healthcare Conference

  12/21/2018

  PerkinElmer, Inc. announced that the Company will present at the J.P. Morgan 37th Annual Healthcare Conference on Wednesday, January 9, 2019, at 10:00 a.m. PT at the Westin St. Francis Hotel in San Francisco

• PerkinElmer Appoints President & Chief Operating Officer

  12/10/2018

  Promotes Prahlad Singh to lead newly created role

• PerkinElmer Receives CE-IVD Mark for Its Vanadis Fully Automated NIPT Platform

  11/26/2018

  Innovative Cost-Effective Solution Provides Pregnant Women Widespread Access to Non-Invasive Prenatal Testing

• PerkinElmer to Present at 2018 Citi Global Healthcare Conference

  11/21/2018

  PerkinElmer, Inc. today announced that the Company will present at the 2018 Citi Global Healthcare Conference on Wednesday, December 5, 2018, at 11:45 a.m. ET at the Lotte New York Palace in New York City.